Variable Endokrinoloji / Tiroid

Thyroiditis — Differential Diagnosis and Management

The common feature of thyroiditis is the DESTRUCTION OF THE THYROID GLAND THROUGH INFLAMMATION and the RELEASE OF STORED READY HORMONE INTO THE BLOOD. This single sentence explains the most critical treatment decision in these conditions: there is LEAKAGE, NOT EXCESS PRODUCTION; therefore, ANTITHYROID DRUGS ARE COMPLETELY INEFFECTIVE.

These drugs work by inhibiting hormone PRODUCTION and are ineffective in a gland that is not producing; administering them only assumes the risk of agranulocytosis and liver damage. The SECOND AND MOST FREQUENTLY OVERLOOKED POINT is the TYPICAL THREE-PHASE COURSE: first, a THYROTOXIC phase due to the release of stored hormone, followed by a HYPOTHYROID phase when the stores are depleted, and finally, in most patients, a RETURN TO NORMAL.

If this course is not recognized, two separate mistakes occur: during the thyrotoxic phase, a patient may be misdiagnosed with permanent hyperthyroidism and unnecessary treatment may be initiated; during the hypothyroid phase, a temporary condition may erroneously lead to LIFELONG MEDICATION. The THIRD POINT is that POSTPARTUM THYROIDITIS is often mistaken for POSTPARTUM DEPRESSION or FATIGUE and not investigated.

Rapid management

COMMON MECHANISM: the thyroid gland is DESTROYED BY INFLAMMATION, and the STORED READY HORMONE is RELEASED into the blood → THERE IS LEAKAGE, NOT EXCESS PRODUCTION.
DIRECT CONSEQUENCE:
ANTITHYROID DRUGS ARE COMPLETELY INEFFECTIVE — these drugs work by blocking PRODUCTION and do not work in a gland that is NOT PRODUCING anyway; when given, only the risks of AGRANULOCYTOSIS and LIVER DAMAGE are taken.
KEY IN DIFFERENTIATION:
RADIOACTIVE IODINE UPTAKE IS DECREASED (in Graves' it is INCREASED) — this single finding separates the two conditions.
TYPICAL THREE-PHASE COURSE: (1) THYROTOXIC PHASE — stored hormone is released; (2) HYPOTHYROID PHASE — stores are depleted; (3) in most patients, RETURN TO NORMAL.
IF THIS COURSE IS UNRECOGNIZED, TWO ERRORS OCCUR: diagnosis of PERMANENT HYPERTHYROIDISM during the thyrotoxic phase leading to unnecessary treatment; LIFELONG MEDICATION for a TEMPORARY condition during the hypothyroid phase.
MAIN TYPES:
Painful and TENDER gland + prior VIRAL INFECTION + marked CRP/ESR elevation → SUBACUTE (granulomatous) thyroiditis; treatment is directed at PAIN.
PAINLESS gland + in the months following childbirth → POSTPARTUM THYROIDITIS; often mistaken for POSTPARTUM DEPRESSION and NEVER INVESTIGATED.
PAINLESS + insidious + antibody positive → HASHIMOTO (chronic autoimmune) thyroiditis; most commonly causes PERMANENT HYPOTHYROIDISM.
PAINFUL + FEVER + prominent local INFECTION signs → RARE but EMERGENCY SUPPURATIVE thyroiditis; carries risk of abscess and airway.
AMIODARONE and IMMUNE CHECKPOINT INHIBITORS can cause thyroiditis.
Rapidly growing mass on a HASHIMOTO background may be LYMPHOMA.
ALL DOSES and MONITORING INTERVALS MUST BE VERIFIED FROM INSTITUTIONAL PROTOCOL.

Drug	Adult	Pediatric	Route	Duration
Knowing that antithyroid drug is ineffective The mechanism of thyrotoxicosis in thyroiditis is entirely different from that in Graves' disease, and this difference determines treatment. In Graves' disease, the gland is stimulated and continuously produces new hormone; antithyroid drugs act by blocking steps of this production process. In thyroiditis, however, the gland is damaged due to inflammation, and the hormones already stored inside leak into the blood. There is no production to block here; the hormone has already been made and is waiting within the gland. Therefore, giving antithyroid drugs is like trying to stop water running in a closed faucet. The result is twofold harm: the drug provides no benefit, and at the same time, unnecessary risks such as sudden drop in white blood cells and liver damage are taken. Moreover, because thyroiditis resolves spontaneously, the patient will recover even if the drug is not given, and any recovery will be falsely attributed to the drug; this erroneous conclusion may lead to unnecessarily prolonged drug use. If symptoms are bothersome, they are managed with a beta blocker.	ANTITHYROID DRUGS ARE NOT GIVEN in thyrotoxicosis due to thyroiditis. The gland is NOT PRODUCING HORMONE and is RELEASEING STORED HORMONE through destruction; drugs that inhibit its production have no benefit in this scenario. Symptom control is provided with BETA BLOCKERS; selection, dose, and contraindications MUST BE VERIFIED FROM INSTITUTIONAL PROTOCOL.	The same principle applies to children; symptom control is done according to pediatric protocol	—	Throughout the thyrotoxic phase
The key to differentiation — radioactive iodine uptake Distinguishing between Graves' disease and thyroiditis in a patient presenting with thyrotoxicosis is essential because the treatment changes entirely, and the clearest finding for this distinction is radioactive iodine uptake. The rationale for this test is simple: the thyroid gland must take in iodine to produce hormones. In Graves' disease, the gland is continuously stimulated and produces hormones intensively, and therefore it strongly takes up the administered radioactive iodine. In thyroiditis, however, the gland is damaged and does not produce; since its ability to take in iodine is reduced, uptake is found to be low. This single finding distinguishes the two clinically very similar conditions. There are also supportive findings: in Graves' disease, the TSH receptor antibody is positive, and blood flow in the gland is significantly increased on ultrasonography; in thyroiditis, blood flow is decreased. In pregnant women, since radioactive substances cannot be used, the distinction should be based on antibodies, ultrasonography, and clinical course.	The most decisive finding in distinguishing thyroiditis from Graves' disease is RADIOACTIVE IODINE UPTAKE: in thyroiditis, UPTAKE IS DECREASED, in Graves' disease, it is INCREASED. If needed, TSH RECEPTOR ANTIBODY, thyroid ULTRASOUND, and BLOOD FLOW can support diagnosis. In PREGNANCY, scintigraphy cannot be used, and differentiation is made by other methods.	In children, imaging choice is done according to pediatric protocol	Imaging and laboratory	At the time of diagnosis
Knowing the three-stage course and explaining it to the patient The most distinctive feature of thyroiditis is that it follows a phased course rather than a one-way course, and not knowing this course leads to two separate mistakes. When the disease begins, due to destruction in the gland, stored hormone is released into the blood, and the patient becomes thyrotoxic; during this period, palpitations, weight loss, and restlessness are observed. After some time, the hormone stores in the gland are depleted, and since the damaged gland cannot produce new hormones, the patient enters a hypothyroid phase; this time, fatigue, cold intolerance, and weight gain occur. In most patients, the gland gradually recovers, and its functions return to normal. When this natural course is not known, the first mistake occurs during the thyrotoxic phase: a diagnosis of permanent hyperthyroidism is made, and permanent treatments such as antithyroid drugs or even radioactive iodine come into consideration; however, the condition will resolve on its own. The second mistake occurs during the hypothyroid phase: thyroid hormone is started with the assumption that a temporary condition will last a lifetime, and treatment is continued for years without questioning. Therefore, if treatment is started during the hypothyroid phase, it should be re-evaluated later to determine if it is truly necessary.	The typical course is THREE-STAGED: THYROTOXIC phase, followed by HYPOTHYROID phase, and eventually in most patients RETURN TO NORMAL. For this reason, a PERMANENT TREATMENT DECISION is NOT MADE during the THYROTOXIC phase, and treatment started in the HYPOTHYROID phase is REVIEWED AT REGULAR INTERVALS as it may be TEMPORARY. Durations and follow-up intervals should be VERIFIED FROM THE INSTITUTIONAL PROTOCOL	The course in children is similar, and follow-up is planned according to the pediatric protocol.	—	For months
Subacute (painful) thyroiditis — treatment is aimed at pain Subacute thyroiditis is the easiest type to recognize among thyroiditis because the pain is prominent, and the patient presents with this complaint. The pain that occurs in the front part of the neck often spreads to the jaw and ear; due to this spread, patients often first visit a dentist or an ENT specialist, and the diagnosis is delayed. On examination, the thyroid gland is distinctly tender to the touch, and this tenderness is very valuable for diagnosis; not palpating the thyroid gland in a patient presenting with neck pain is the most common reason for missing this diagnosis. The history usually reveals an upper respiratory tract infection that occurred a few weeks earlier. In the laboratory, inflammatory markers are significantly elevated, and this elevation is a distinguishing feature of the condition. Treatment targets the pain, not the disease itself, because the process resolves spontaneously; glucocorticoids are used in cases where painkillers are ineffective or the condition is severe. The response to this treatment is usually rapid, but symptoms can recur if discontinued early.	Pain and tenderness in the FRONT NECK AREA, a history of PRIOR VIRAL UPPER RESPIRATORY TRACT INFECTION, FEVER, and significant increases in CRP and SEDIMENTATION suggest this diagnosis. Treatment is AIMED AT PAIN and usually starts with NON-STEROIDAL PAIN RELIEVERS; in cases where there is no response or in severe cases, GLUCOCORTICOIDS come into consideration. Medication choice, doses, and tapering plan SHOULD BE CONFIRMED FROM THE INSTITUTIONAL PROTOCOL	Rare in children; pain management is done according to the pediatric protocol	Oral	Until the pain subsides
Postpartum thyroiditis — mistaken for depression and overlooked Postpartum thyroiditis is the type of thyroiditis most often overlooked due to its painless course and the unique conditions of the postpartum period. During this period, the new mother is already tired, her sleep is fragmented, her mood fluctuates, and her weight changes. The symptoms of thyroiditis blend perfectly into this picture: in the thyrotoxic phase, palpitations, restlessness, and weight loss are seen; in the hypothyroid phase, fatigue, cold intolerance, weight gain, and depressive symptoms appear. Symptoms of both phases are interpreted as postpartum depression or the natural fatigue associated with new motherhood, and thyroid function is never evaluated. This is a completely preventable delay in diagnosis because all that is needed is a simple blood test. Another significance of the condition is that a portion of women who experience postpartum thyroiditis develop permanent hypothyroidism in later years; therefore, even if these women recover, they should be monitored long-term. Additionally, there is a possibility of recurrence in subsequent pregnancies, and this information should be given to the patient.	IN THE MONTHS AFTER CHILDBIRTH, FATIGUE, PALPITATIONS, RESTLESSNESS, WEIGHT CHANGES, and MOOD CHANGES SHOULD PROMPT AN ASSESSMENT OF THYROID FUNCTION. This condition is often mistaken for POSTPARTUM DEPRESSION or FATIGUE RELATED TO NEW MOTHERHOOD and IS NOT INVESTIGATED AT ALL. Screening and follow-up intervals SHOULD BE VERIFIED BY INSTITUTIONAL PROTOCOL	Not applied	Laboratory	Postpartum period
Hashimoto's thyroiditis and long-term follow-up Chronic autoimmune thyroiditis develops as a result of the immune system gradually and continuously damaging thyroid tissue and is the most common cause of permanent hypothyroidism. Unlike other thyroiditis types, this process is irreversible; functional tissue gradually decreases over the years. Therefore, patients are encountered in three distinct situations. Some are euthyroid, with only antibody positivity and goiter present; treatment is not required in these patients, but monitoring should continue because there is a possibility of developing hypothyroidism over time. The second group has subclinical hypothyroidism, and the treatment decision is individualized. The third group has overt hypothyroidism and requires treatment. A common mistake here is considering antibody positivity alone as a reason for treatment; antibodies indicate the presence of the disease, but the treatment decision is based on functional tests. Another important point is that in these patients, when a rapidly enlarging mass appears, thyroid lymphoma should be considered; this association is rare but if unknown, the diagnosis may be delayed.	In a patient with a PAINLESS, INSIDIOUS course and POSITIVE thyroid ANTIBODIES, chronic autoimmune thyroiditis is considered; this picture is THE MOST COMMON CAUSE OF PERMANENT HYPOTHYROIDISM. If the patient is euthyroid, TREATMENT IS NOT REQUIRED but MONITORING CONTINUES. The positivity of antibodies ALONE IS NOT A REASON FOR TREATMENT. Monitoring intervals SHOULD BE VERIFIED FROM THE INSTITUTIONAL PROTOCOL.	Due to its effects on growth and puberty in children, follow-up is conducted in collaboration with pediatric endocrinology.	—	The reason why long-term
Rare but urgent suppurative thyroiditis Bacterial infection of the thyroid gland is rare because the gland has a rich blood supply, high iodine content, and is surrounded by a capsule; these features protect the gland against infections. However, when this protection is breached, the resulting condition progresses severely and carries an urgency completely different from other thyroiditis types. Distinguishing features are pronounced fever, redness and increased warmth in the neck, severe tenderness, and rapid deterioration in general condition. It may be confused with subacute thyroiditis since pain and mild fever can also occur in subacute thyroiditis; however, in subacute thyroiditis, the general condition is preserved and the course does not progress this rapidly. The infection can form an abscess and expand in the neck, pressing on the trachea; therefore, airway assessment is a priority. It is more common in immunocompromised patients and children. In children with recurrent cases, a congenital connection between the pharynx and the thyroid should be investigated; if this connection is not corrected, the infection continues to recur.	DISTINCT PAIN, HIGH FEVER, REDNESS AND HEAT INCREASE IN THE NECK, rapid deterioration, and impaired general condition should raise the suspicion of BACTERIAL INFECTION of the gland. This condition is RARE but URGENT; it carries risk of ABSCESS and AIRWAY OBSTRUCTION. Imaging, culture, antibiotic choice, and drainage decision should be VERIFIED BY THE INSTITUTIONAL PROTOCOL.	In children with recurrent cases, an anatomical connection (piriform sinus fistula) should be investigated.	—	Emergency evaluation

Alternative

In Graves’ disease, radioactive iodine uptake is increased and antithyroid drugs are effective; it is handled in a separate protocol.
Thyroid dysfunction due to amiodarone can create a thyroiditis-like destructive pattern in one type (relevant protocol).
Immune checkpoint inhibitors can cause thyroiditis, and the course is staged (relevant protocol).
Thyroid lymphoma can appear as a rapidly growing mass on the background of Hashimoto’s thyroiditis.
Taking thyroid hormone from outside also proceeds with low uptake and should be distinguished from thyroiditis.
Riedel thyroiditis is a very rare condition where the gland hardens and adheres to surrounding tissues.
Other causes of neck pain (pharyngitis, dental problems, cervical pathology) can be confused with subacute thyroiditis.

Red flags

In thyrotoxicosis due to thyroiditis, starting ANTITHYROID DRUGS → the gland DOES NOT PRODUCE, it RELEASES STORED HORMONE; the medication is COMPLETELY INEFFECTIVE and only poses a risk of side effects.
When thyroiditis resolves on its own, attributing the resolution to ANTITHYROID DRUG → the patient uses the drug unnecessarily for a long time.
During the THYROTOXIC phase, diagnosing PERMANENT HYPERTHYROIDISM and considering PERMANENT TREATMENTS such as radioactive iodine or surgery → the condition WILL RESOLVE ON ITS OWN.
Continuing treatment started during the HYPOTHYROID phase for YEARS without questioning → this phase may be TEMPORARY; treatment should be reviewed at regular intervals.
Not palpating the thyroid gland in a patient presenting with neck pain → is the MOST COMMON reason for missing subacute thyroiditis.
Neck pain radiating to the jaw and ear being mistaken for a dental or ENT problem → delays the diagnosis of subacute thyroiditis.
Postpartum fatigue, palpitations, and mood changes being mistaken for POSTPARTUM DEPRESSION or FATIGUE → all that is needed is A SIMPLE BLOOD TEST.
Not following up at all after a woman experiences postpartum thyroiditis → a portion of them may develop PERMANENT HYPOTHYROIDISM in the following years.
Considering ANTIBODY POSITIVITY alone as a reason for treatment → antibodies show the PRESENCE of the disease, treatment decisions are based on FUNCTIONAL TESTS.
A rapidly growing mass on a HASHIMOTO background being simply monitored → could be THYROID LYMPHOMA.
Assuming OBVIOUS FEVER, redness in the neck, and RAPID DETERIORATION as subacute thyroiditis → could be SUPPURATIVE thyroiditis; it carries the risk of ABSCESS and AIRWAY OBSTRUCTION.
Requesting scintigraphy for differentiation in a PREGNANT WOMAN → radioactive substances CANNOT BE USED in pregnancy; differentiation is based on antibodies, ultrasonography, and clinical course.

Disposition and follow-up

Green zone: Painless, mild thyroiditis: outpatient follow-up, explaining the staged course to the patient, and planned thyroid function checks; antithyroid drugs are not given.
Yellow zone: Obvious painful subacute thyroiditis, prominent thyrotoxic symptoms, pregnancy or postpartum period, accompanying heart disease, mass growing on Hashimoto background: accelerated evaluation and referral to endocrinology.
Red zone: High fever, neck redness and warmth, rapidly worsening general condition, shortness of breath or stridor: consider suppurative thyroiditis and airway obstruction, urgent evaluation and hospitalization are required. In severe thyrotoxic cases, thyroid storm is evaluated separately (relevant protocol).

Key clinical points

READ FIRST — there is leakage, no production

COMMON MECHANISM: the thyroid gland IS DESTROYED BY INFLAMMATION → STORED READY HORMONE LEAKS into the blood | DIFFERENCE WITH GRAVES: in Graves, the gland is STIMULATED and CONTINUOUSLY PRODUCES NEW HORMONE; in thyroiditis, the hormone is ALREADY MADE and WAITING INSIDE THE GLAND | DIRECT CONSEQUENCE: ANTITHYROID DRUGS act by blocking the STEPS OF THE PRODUCTION PROCESS → USELESS in a gland that is NOT PRODUCING anyway | ANALOGY: TRYING TO STOP WATER FLOWING THROUGH A CLOSED TAP | TWO-WAY HARM: (1) the drug PROVIDES NO BENEFIT (2) the risks of AGRANULOCYTOSIS and LIVER DAMAGE are taken UNNECESSARILY | ADDITIONAL TRAP: thyroiditis is a SELF-LIMITING process → if the drug is given, the patient WILL IMPROVE ALREADY and the IMPROVEMENT WILL BE ATTRIBUTED TO THE DRUG → this false inference leads the patient to USE THE DRUG UNNECESSARILY FOR A LONG TIME | CORRECT APPROACH: if symptoms are bothersome they are controlled with BETA BLOCKERS | KEY TO DIFFERENTIATION: RADIOACTIVE IODINE UPTAKE — decreased in thyroiditis, increased in Graves | LOGIC: the gland MUST ABSORB IODINE to produce hormone; the damaged gland HAS LOST this ability

The mechanism of thyrotoxicosis in thyroiditis is completely different from that in Graves disease. In Graves disease, the gland is stimulated and continuously produces new hormone; antithyroid drugs prevent this production. In thyroiditis, however, the gland is damaged and stored ready hormone leaks into the blood; there is no production to inhibit. Therefore, antithyroid drugs provide no benefit, but unnecessarily carry the risks of agranulocytosis and liver damage. Furthermore, since thyroiditis resolves spontaneously, the improvement is attributed to the drug, leading to prolonged unnecessary use. Symptoms are managed with beta blockers. The key to differentiation is radioactive iodine uptake: the gland must take in iodine to produce hormone, and since the damaged gland has lost this ability, uptake decreases.

THREE-PHASE COURSE — the source of two separate errors

STAGE 1 — THYROTOXIC: due to the destruction in the gland, STORED HORMONE is released → PALPITATIONS, WEIGHT LOSS, RESTLESSNESS | STAGE 2 — HYPOTHYROID: HORMONE STORE in the gland is DEPLETED and the DAMAGED GLAND CANNOT PRODUCE NEW HORMONE → FATIGUE, COLD INTOLERANCE, WEIGHT GAIN | STAGE 3 — RETURN TO NORMAL: in most patients, the gland gradually RECOVERS | IF THIS COURSE IS NOT KNOWN, TWO MISTAKES ARE MADE | MISTAKE 1 (during thyrotoxic phase): the patient is diagnosed with PERMANENT HYPERTHYROIDISM → antithyroid drugs, even PERMANENT TREATMENTS like RADIOACTIVE IODINE are considered | YET THE CONDITION WILL PASS ON ITS OWN | MISTAKE 2 (during hypothyroid phase): thyroid hormone is started with the assumption that a TEMPORARY condition will last a LIFETIME, and the treatment is continued for YEARS WITHOUT ANY QUESTIONING | RULE: during the thyrotoxic phase, NO PERMANENT TREATMENT DECISION SHOULD BE MADE | If treatment has been started in the hypothyroid phase, it should be REEVALUATED LATER TO SEE IF IT IS REALLY NECESSARY | Duration and follow-up intervals MUST BE CONFIRMED FROM INSTITUTIONAL PROTOCOL

The most distinguishing feature of thyroiditis is its staged course. First, stored hormone is released, and the patient becomes thyrotoxic; then the store is depleted, and the patient enters the hypothyroid phase; in most patients, the gland recovers, and functions return to normal. When this course is unknown, two mistakes occur. During the thyrotoxic phase, the patient is diagnosed with permanent hyperthyroidism, and permanent treatments are considered, whereas the condition will pass spontaneously. During the hypothyroid phase, thyroid hormone is started with the assumption that a temporary condition will last a lifetime, and treatment continues for years without questioning. Therefore, no permanent decision should be made during the thyrotoxic phase, and treatment started in the hypothyroid phase should be reassessed later.

Subacute thyroiditis — PALPATE the thyroid in neck pain

THE EASIEST TYPE TO RECOGNIZE because the PAIN IS PROMINENT | CLINIC: pain in the FRONT AREA of the neck, often RADIATING TO THE JAW AND EAR | BECAUSE OF THIS RADIATION, patients often FIRST VISIT THE DENTIST or an ENT specialist → DIAGNOSIS IS DELAYED | EXAMINATION — VERY VALUABLE FOR DIAGNOSIS: thyroid gland is DISTINCTLY TENDER to palpation | MOST COMMON REASON FOR MISSING: failure to palpate the thyroid gland in a patient presenting with NECK PAIN | HISTORY: usually a UPPER RESPIRATORY TRACT INFECTION a few WEEKS earlier | LABORATORY: INFLAMMATORY MARKERS (CRP, sedimentation) ARE DISTINCTLY ELEVATED — a distinguishing feature of the condition | TREATMENT TARGETS THE PAIN, NOT THE DISEASE ITSELF because THE CONDITION RESOLVES SPONTANEOUSLY | Usually starts with NON-STEROIDAL PAIN RELIEVERS; in unresponsive or severe cases, GLUCOCORTICOID | Response is generally RAPID but symptoms MAY RECUR IF STOPPED EARLY | Choice of drug, doses, and tapering plan SHOULD BE VERIFIED FROM THE INSTITUTIONAL PROTOCOL

Subacute thyroiditis is the easiest type to recognize because the pain is prominent. Pain in the front region of the neck often radiates to the jaw and ear; therefore, patients first visit the dentist or an ENT specialist and diagnosis is delayed. On examination, the thyroid gland is distinctly tender, and this finding is very valuable for diagnosis; failure to palpate the thyroid in a patient presenting with neck pain is the most common reason this diagnosis is missed. The history usually includes an upper respiratory tract infection a few weeks earlier, and inflammatory markers are distinctly elevated. Treatment targets the pain because the course resolves spontaneously; glucocorticoids are used in unresponsive cases, and symptoms may recur if stopped early.

Postpartum thyroiditis — mistaken for depression, it is never checked

THE MOST FREQUENTLY OVERLOOKED TYPE OF THYROIDITIS — because it is PAINLESS and overlaps with the UNIQUE CONDITIONS OF THE POSTPARTUM PERIOD | DURING THIS PERIOD, THE NEW MOTHER IS ALREADY: TIRED | SLEEPING IS INTERRUPTED | MOOD IS FLUCTUATING | WEIGHT IS CHANGING | THYROIDITIS SYMPTOMS COMPLETELY MIX WITH THIS PICTURE: in the thyrotoxic phase PALPITATIONS, RESTLESSNESS, WEIGHT LOSS | in the hypothyroid phase FATIGUE, CHILLINESS, WEIGHT GAIN, and DEPRESSIVE SYMPTOMS | SYMPTOMS OF BOTH PHASES ARE INTERPRETED AS 'POSTPARTUM DEPRESSION' or 'natural fatigue related to new motherhood' → THYROID FUNCTIONS ARE NOT EVALUATED AT ALL | THIS IS ENTIRELY A PREVENTABLE DIAGNOSTIC DELAY because ALL THAT IS NEEDED IS A SIMPLE BLOOD TEST | LONG TERM — TWO IMPORTANT PIECES OF INFORMATION: (1) in SOME OF THESE WOMEN, PERMANENT HYPOTHYROIDISM develops in later years → THEY SHOULD BE MONITORED LONG TERM EVEN IF THEY RECOVER | (2) IN SUBSEQUENT PREGNANCIES, the picture CAN RECURRE and this information SHOULD BE GIVEN TO THE PATIENT

Postpartum thyroiditis is the type most frequently overlooked because it is painless. During this period, the new mother is already tired, her sleep is interrupted, her mood fluctuates, and her weight is changing. Thyroiditis symptoms blend exactly into this picture: palpitations and weight loss during the thyrotoxic phase, fatigue and depressive symptoms during the hypothyroid phase. Both phases are interpreted as postpartum depression or natural fatigue, and thyroid functions are not evaluated at all. This is an entirely preventable diagnostic delay because all that is needed is a simple blood test. Additionally, in some of these women, permanent hypothyroidism develops in later years, and the picture can recur in subsequent pregnancies; both pieces of information should be given to the patient.

Hashimoto and rare but urgent suppurative thyroiditis

HASHIMOTO (chronic autoimmune) — DIFFERENCE FROM OTHERS: this process is NOT REVERSIBLE; over the years, FUNCTIONAL TISSUE GRADUALLY DECREASES → IT IS THE MOST COMMON CAUSE OF PERMANENT HYPOTHYROIDISM | IT APPEARS IN THREE SCENARIOS: EUTHYROID (only antibody positivity and goiter) → NO TREATMENT is needed but MONITORING continues | SUBCLINICAL hypothyroidism → decision is INDIVIDUALIZED | OVERT hypothyroidism → treatment is required | COMMON MISTAKE: CONSIDERING ANTIBODY POSITIVITY ALONE AS A REASON FOR TREATMENT → antibodies indicate the PRESENCE of the disease, TREATMENT DECISION IS BASED ON FUNCTION TESTS | WARNING: in these patients, if a RAPIDLY GROWING mass appears, THYROID LYMPHOMA should be considered — it is rare but if unknown, DIAGNOSIS IS DELAYED | SUPPURATIVE THYROIDITIS — RARE but EMERGENCY: the gland is normally PROTECTED by RICH BLOOD FLOW, HIGH IODINE CONTENT, and CAPSULE; when this protection is BREACHED, the condition is SEVERE | DISTINGUISHING FEATURES: HIGH FEVER | REDNESS and INCREASED TEMPERATURE in the neck | SEVERE TENDERNESS | RAPID DETERIORATION in general condition | DIFFERENCE FROM SUBACUTE: in subacute, GENERAL CONDITION IS PRESERVED and the course is NOT THIS RAPID | RISK: ABSCESS FORMATION and PRESSURE ON THE TRACHEA → AIRWAY ASSESSMENT IS PRIORITY | IN CHILDREN WITH RECURRENT cases, a CONGENITAL CONNECTION between PHARYNX and THYROID is investigated

Chronic autoimmune thyroiditis is not reversible and is the most common cause of permanent hypothyroidism. Patients present as euthyroid, subclinical hypothyroid, or overt hypothyroid; in euthyroid patients, treatment is not needed but monitoring continues. A common mistake is considering antibody positivity alone as a reason for treatment; antibodies indicate the presence of the disease, treatment decision depends on function tests. In this context, if a rapidly growing mass appears, thyroid lymphoma should be considered. Suppurative thyroiditis is rare but an emergency; it is distinguished by pronounced fever, redness in the neck, severe tenderness, and rapid deterioration of the general condition. Because of the risk of abscess formation and pressure on the trachea, airway assessment is a priority.

Detailed assessment

Diagnostic and decision reasoning

Clinical framework

Overview

Thyroiditis is a group of diseases that occur with inflammation of the thyroid gland and are based on different causes. Their common feature is the destruction of the gland and the release of stored hormone into the bloodstream; therefore, the resulting thyrotoxicosis is caused by leakage rather than overproduction.

This distinction determines the treatment: antithyroid drugs are completely ineffective in these conditions because they work by blocking production and only pose a risk of side effects. The most decisive finding that distinguishes thyroiditis from Graves' disease is radioactive iodine uptake; it is decreased in thyroiditis and increased in Graves' disease.

The typical course is three stages: first the thyrotoxic phase, then the hypothyroid phase when the stores are depleted, and finally, in most patients, a return to normal. When this course is unknown, unnecessary permanent treatment decisions are made during the thyrotoxic phase, and temporary hormone deficiency is treated lifelong during the hypothyroid phase.

The main types are painful subacute thyroiditis, painless postpartum thyroiditis which is often mistaken for postpartum depression, chronic autoimmune thyroiditis which is the most common cause of permanent hypothyroidism, and rare but emergency bacterial thyroiditis.

Differential diagnosis and assessment

Key considerations

Graves' disease is distinguished by increased radioactive iodine uptake and positive TSH receptor antibody (according to the relevant protocol).
Hyperfunctioning nodule is differentiated by focal uptake on scintigraphy, and antithyroid drugs are effective.
External intake of thyroid hormone is differentiated by low uptake and low thyroglobulin; medication history should be questioned.
Amiodarone-induced thyroid dysfunction occurs through two different mechanisms and its treatment varies according to this distinction (according to the relevant protocol).
Thyroid lymphoma can present as a rapidly growing mass on the background of Hashimoto’s disease.
Anaplastic thyroid carcinoma can mimic suppurative thyroiditis with a rapidly growing hard mass.
Other causes of neck pain can lead to subacute thyroiditis being overlooked; the thyroid should always be examined manually.
Postpartum depression is the condition most commonly confused with postpartum thyroiditis and is distinguished by thyroid tests.

Clinical decision reasoning

Why it matters

The points determining clinical outcomes in the management of thyroiditis stem from the mechanism and natural course of the condition. The first and most fundamental point is that thyrotoxicosis is caused by leakage; since the gland does not produce hormones, antithyroid drugs are ineffective, and when administered, only pose a serious risk of side effects.

Additionally, since thyroiditis resolves spontaneously, improvement is mistakenly attributed to medication, leading to prolonged unnecessary use. The second point is the discriminative power of radioactive iodine uptake; because the gland must take up iodine to produce hormones, uptake in the damaged gland is found to be low, and this single finding distinguishes two clinically similar conditions.

The third point is the three-stage course, and ignorance of this course leads to two opposing mistakes; permanent treatment decisions are made during the thyrotoxic phase, and temporary conditions in the hypothyroid phase result in lifelong medication being started. The fourth point is the value of examination in subacute thyroiditis; because pain radiates to the jaw and ear, patients are referred to other physicians and the thyroid is often not palpated in neck pain, delaying diagnosis.

The fifth point is the overlap of postpartum thyroiditis with postpartum depression; this is a completely preventable delay because all that is needed is a simple blood test. Finally, suppurative thyroiditis is rare but carries a separate urgency due to the risk of abscess and airway compression.

Safety and monitoring

Complications and safety

Critical complications

Agranulocytosis and liver damage due to unnecessary antithyroid drug use are completely preventable harms.
Permanent treatment decisions made during the thyrotoxic phase (radioactive iodine, surgery) lead to irreversible outcomes.
Continuing treatment initiated during the hypothyroid phase without questioning leads to unnecessary lifelong medication use.
The development of permanent hypothyroidism in chronic autoimmune thyroiditis is an expected outcome and requires monitoring.
In some individuals who experience postpartum thyroiditis, permanent hypothyroidism develops years later.
In suppurative thyroiditis, abscess formation and compression of the trachea threaten the airway.
Thyroid lymphoma developing on the background of Hashimoto's thyroiditis presents as a rapidly growing mass.
Early discontinuation of glucocorticoid treatment in subacute thyroiditis leads to recurrence of symptoms.

Special patient populations

Special considerations

Scintigraphy cannot be used in pregnant women; differentiation is based on antibodies, ultrasonography, and clinical course.
Symptoms in women in the postpartum period overlap with depression and fatigue; thyroid functions should be evaluated.
Those who have had postpartum thyroiditis should be monitored in the long term, and the possibility of recurrence in subsequent pregnancies should be explained.
Suppurative thyroiditis is more common in immunocompromised patients.
In children with recurrent suppurative thyroiditis, a congenital connection between the pharynx and thyroid should be investigated.
In elderly patients, the thyrotoxic phase may be silent and may only present as atrial fibrillation.
In patients with heart disease, symptom control during the thyrotoxic phase is a priority.
In patients using amiodarone or immune checkpoint inhibitors, thyroiditis may be drug-induced (see relevant protocol).

Follow-up and reassessment

Follow-up plan

The main purpose of thyroiditis follow-up is to manage its staged course correctly and not to apply permanent treatments for conditions that are temporary. When diagnosed, it should be clearly explained to the patient that the course is staged and symptoms may change over time; without this information, the patient may worry thinking that a new disease has developed in the second stage.

Thyroid function tests should be repeated at intervals specified in the institutional protocol to monitor the transition between stages. In the thyrotoxic phase, a permanent treatment decision should not be made, and symptom control should suffice.

If treatment was started during the hypothyroid phase, it should be recorded that this treatment may be temporary and reassessed later to determine if it is truly necessary; without this reassessment, the patient may use unnecessary medication for years. If glucocorticoids were used in subacute thyroiditis, the tapering plan should be followed, and the patient should be informed that symptoms may recur if stopped early.

Women who have had postpartum thyroiditis should be monitored long-term even after recovery, and the possibility of recurrence in subsequent pregnancies should be communicated. Treatment is not started in euthyroid patients with chronic autoimmune thyroiditis, but monitoring is continued; in these patients, if a rapidly enlarging mass appears, evaluation should not be delayed.

In children who have had suppurative thyroiditis, follow-up is not considered complete without investigating an anatomical connection.